Patents by Inventor Howard C. Coleman
Howard C. Coleman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
SYSTEMS AND METHODS FOR QUANTIFICATION AND PRESENTATION OF MEDICAL RISK ARISING FROM UNKNOWN FACTORS
Publication number: 20220293235Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.Type: ApplicationFiled: April 8, 2022Publication date: September 15, 2022Applicant: Invitae CorporationInventors: Howard C. COLEMAN, Robert D. Patterson, Jessica Oesterheld, Rajeev V. Pany, Kristine Ashcraft -
Systems and methods for quantification and presentation of medical risk arising from unknown factors
Patent number: 11302431Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.Type: GrantFiled: January 31, 2019Date of Patent: April 12, 2022Assignee: Invitae CorporationInventors: Howard C. Coleman, Robert D. Patterson, Jessica Oesterheld, Rajeev V. Pany, Kristine Ashcraft -
Publication number: 20200402673Abstract: A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.Type: ApplicationFiled: April 3, 2020Publication date: December 24, 2020Applicant: YOUSCRIPT INC.Inventors: Jessica Oesterheld, Robert D. Patterson, Howard C. Coleman
-
SYSTEMS AND METHODS FOR QUANTIFICATION AND PRESENTATION OF MEDICAL RISK ARISING FROM UNKNOWN FACTORS
Publication number: 20190164637Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.Type: ApplicationFiled: January 31, 2019Publication date: May 30, 2019Applicant: YouScript Inc.Inventors: Howard C. Coleman, Robert D. Patterson, Jessica Oesterheld, Rajeev V. Pany, Kristine Ashcraft -
Systems and methods for quantification and presentation of medical risk arising from unknown factors
Patent number: 10210312Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.Type: GrantFiled: January 31, 2014Date of Patent: February 19, 2019Assignee: Youscript Inc.Inventors: Howard C. Coleman, Robert D. Patterson, Jessica Oesterheld, Rajeev V. Pany, Kristine Ashcraft -
SYSTEMS AND METHODS FOR QUANTIFICATION AND PRESENTATION OF MEDICAL RISK ARISING FROM UNKNOWN FACTORS
Publication number: 20140222400Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.Type: ApplicationFiled: January 31, 2014Publication date: August 7, 2014Applicant: Genelex CorporationInventors: Howard C. Coleman, Robert D. Patterson, Jessica Oesterheld, Rajeev V. Pany, Kristine Ashcraft -
Publication number: 20140142986Abstract: A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.Type: ApplicationFiled: January 24, 2014Publication date: May 22, 2014Applicant: GENELEX CORPORATIONInventors: Jessica Oesterheld, Robert D. Patterson, Howard C. Coleman
-
Patent number: 8676608Abstract: A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.Type: GrantFiled: October 8, 2012Date of Patent: March 18, 2014Assignee: Genelex CorporationInventors: Jessica Oesterheld, Robert D Patterson, Howard C Coleman
-
Publication number: 20130066649Abstract: A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.Type: ApplicationFiled: October 8, 2012Publication date: March 14, 2013Applicant: GENELEX CORPInventors: Jessica Oesterheld, Robert D. Patterson, Howard C. Coleman
-
Patent number: 8311851Abstract: A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.Type: GrantFiled: December 9, 2011Date of Patent: November 13, 2012Assignee: Genelex CorpInventors: Robert D Patterson, Jessica Oesterheld, Howard C Coleman
-
Patent number: 8099298Abstract: A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.Type: GrantFiled: February 14, 2008Date of Patent: January 17, 2012Assignee: Genelex, incInventors: Howard C Coleman, Jessica Oesterheld, Robert D Patterson
-
Publication number: 20090094059Abstract: A computerized tool and method for delivery of pharmacogenetic and pharmacological information, comprising a core system having algorithms and databases for storing, collating, accessing, cross-referencing, and interpreting genetic and pharmacologic data, with a graphical user interface for a client network of providers of laboratory genetic testing services to access the core services under contract. The system includes “paypoints” in support of improved business models. Included are mechanisms for ‘pass through’ third party and insurance reimbursement for interpretive reports, insurance reimbursement for on-line access to pharmacogenetic information at the point of care, tools for market segmentation, and a conversion tool for capturing new subscribers. Also disclosed are tools and predictive algorithms for preventing drug-drug and drug-gene adverse drug reactions.Type: ApplicationFiled: February 14, 2008Publication date: April 9, 2009Applicant: Genelex, IncInventors: Howard C. Coleman, Jessica Oesterheld, Robert D. Patterson
-
Patent number: 5106477Abstract: A fluid circulation apparatus for an electrophoresis device is disclosed. The fluid circulation device has an electrode gas retaining means communicating with the two reservoirs of the electrophoresis device. The electrode gas retaining means is disposed to trap electrode produced gas at a level below the fluid level in the remainder of the electrophoresis device so that fluid in the electrode gas retaining means has a pressure head greater than the pressure at the fluid level in the remainder of the electrophoresis device. The resulting fluid pressure differential causes the fluid flow between the two reservoirs of the electrophoresis device through the electrode gas retaining means.Type: GrantFiled: November 6, 1990Date of Patent: April 21, 1992Assignee: Genelex CorporationInventor: Howard C. Coleman